Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Prakash Y. Khandave
Observed names:
Prakash Y Khandave,
Prakash Yadnyakant Khandave
Institutions:
National Institute of Pharmaceutical Education and Research,
National Institute of Pharmaceutical Education and Research
Observed institutions:
National Institute of Pharmaceutical Education and Research,
National Institute of Pharmaceutical Education and Research,
National Institute of Pharmaceutical Education and Research
ORCID:
0009-0009-6278-0552
Observed ORCID:
0009-0009-6278-0552
OpenAlex ID:
A5060863148
Fused human paraoxonase 1 as a prophylactic agent against organophosphate poisoning
2023
·
Prakashkumar Dobariya
, Pratik Adhya
, et al.
·
Enzyme and Microbial Technology
·
15
Photosensitizer-Antibody Conjugates (PhotoBodies): Emerging Frontiers in the Field of Theranostics
2025
·
Sampada Sharad Kulkarni
, Prakash Y. Khandave
, et al.
·
Pharmaceutical Research
·
8
Lignin-based biopharmaceuticals from nature to medicine: current trends, future prospects and emerging challenges
2026
·
Kshitij Rawat
, Ravneet Kaur
, et al.
·
RSC Applied Interfaces
·
7
PDF
Chemotherapeutic Drug—Antibody Conjugates (ChemoBodies): Recent Advances and Future Directions
2025
·
Abhishek K. Tiwatane
, Prakash Y. Khandave
, et al.
·
Current Oncology Reports
·
7
Human Paraoxonase 1: From Bloodstream Enzyme to Disease Fighter & Therapeutic Intervention
2024
·
Prakash Yadnyakant Khandave
, Khushi Goyal
, et al.
·
Current Protein and Peptide Science
·
4
Warfare Nerve Agents and Paraoxonase-1 as a Potential Prophylactic Therapy against Intoxication
2024
·
A.R. Satvik Iyengar
, Prakash Y. Khandave
, et al.
·
Protein and Peptide Letters
·
4
Radioligand–Antibody Conjugates: Integrating Antibody Engineering, Chelator Chemistry, and Radioligands for Precision Theranosis
2025
·
Prakash Y. Khandave
, Pravin U. Gudavalekar
, et al.
·
Molecular Diagnosis & Therapy
·
3
Challenges and advances in the development of antidotes against A-series nerve agents
2025
·
Rajan K. Tripathy
, Khushi Goyal
, et al.
·
Archives of Toxicology
·
3
Correction: Photosensitizer-Antibody Conjugates (PhotoBodies): Emerging Frontiers in the Field of Theranostics
2026
·
Sampada Sharad Kulkarni
, Prakash Y. Khandave
, et al.
·
Pharmaceutical Research
·
2
PDF
PolyBodies for the Treatment of Respiratory Syncytial Virus Infection
2025
·
Yenisetti Rajendra Prasad
, Sandeep
, et al.
·
Drug Discovery Today
·
2
Role of paraoxonase 1 in organophosphate G-series nerve agent poisoning and future therapeutic strategies
2024
·
Rajan K. Tripathy
, Prakash Y. Khandave
, et al.
·
Archives of Toxicology
·
2
Generative AI-Designed Immunoglobulin Domain Antibodies (IgDAbs) Against the Fusion Protein as a Neutralizing Agent for Respiratory Syncytial Virus
2026
·
Yenisetti Rajendra Prasad
, Prakash Y. Khandave
, et al.
·
Pharmaceutical Research
The rise of bispecific T-cell engager (BsTCE) antibodies: a potentially game-changing approach for breast cancer therapy?
2026
·
Pravin U. Gudavalekar
, Prakash Y. Khandave
, et al.
·
Drug Discovery Today
Author response for "Lignin-based biopharmaceuticals from nature to medicine: current trends, future prospects and emerging challenges"
2026
·
Kshitij Rawat
, Ravneet Kaur
, et al.
·
Publons reviews and discussion
Nanophotobody-mediated EGFR targeting using lignin nanoassemblies enhances photodynamic efficacy in breast cancer
2026
·
Kshitij Rawat
, Prakash Y. Khandave
, et al.
·
RSC Pharmaceutics
Show more works
View as search
Works count:
15
Citation count:
57
H-index:
4
I10-index:
1
Year
Topic
Type